Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03789617
Status:
RECRUITING
Last Update Posted:
2022-07-11
First Post:
2018-12-27
Brief Title:
A Multi-center Single-arm Open Phase IIIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell EBV Specific Autologous CD8 T Cell in Patients With Treatment Failed Epstein Barr Virus EBV-Positive Malignancies
Sponsor:
Eutilex
Organization:
Eutilex
Organization Data
Organization:
Eutilex
Class:
INDUSTRY
Study ID:
EBViNT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eutilex
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None